Nanexa (NANEX) Shares Surge Over 150% Following $1.33 Billion Licensing Deal with Novo Nordisk
Nanexa's shares surged over 150% following a significant $1.33 billion licensing agreement with Novo Nordisk, marking a pivotal moment for the company and its PharmaShell technology in the drug delivery sector.